A PHASE I/II, MULTICENTER, OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF COBIMETINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS
Principal Investigator(s)
Langevin,Anne-Marie R
Funded by
SLOAN -KETTERING INSTITUTE FOR CANCER RE
Research Start Date
Status
Active